Comparison of successful and unsuccessful islet/sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice

Cell Transplantation

Volumn 16, Issue 10, 2008, Pages 1029-1038

  Dufour, Jannette M ^a   Lord, Sarah J ^b   Kin, Tatsuya ^b   Rayat, Gina R ^b   Dixon, Doreen E ^b   Bleackley, R Chris ^b   Korbutt, Gregory S ^b   Rajotte, Ray V ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diabetes; Islet; Sertoli cell; Transplantation

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY CAPSULE; KIDNEY TUBULE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SERTOLI CELL TRANSPLANTATION; STREPTOZOCIN DIABETES;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, EXPERIMENTAL; GRAFT SURVIVAL; ISLETS OF LANGERHANS TRANSPLANTATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; SERTOLI CELLS; STREPTOZOCIN; TRANSPLANTATION, HOMOLOGOUS;

MUS; RODENTIA;

EID: 44349083165     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000007783472417     Document Type: Article

References (23)

1. Barker, C. F.; Billingham, R. E. Immunologically privileged sites. Adv. Immunol. 25:1-54; 1977.
2. Dufour, J. M.; Rajotte, R. V.; Korbutt, G. S.; Emerich, D. F. Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes. Immunol. Invest. 32:275-297; 2003.
3. Dym, M.; Fawcett, D. W. The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium. Biol. Reprod. 3:308-326; 1970.
4. Emamuallee, J. A.; Shapiro, A. M. J. Factors influencing the loss of β-cell mass in islet transplantation. Cell Transplant. 16:1-8; 2007
5. Griswold, M. D. The central role of Sertoli cells in spermatogenesis. Semin. Cell Dev. Biol. 9:411-416; 1998.
6. Inzucchi, S. E. Classification and diagnosis of diabetes mellitus. In: Porte, Jr., D.; Sherwin, R. S.; Baron, A., eds. Ellenberg and Rifkin's diabetes mellitus, 6th ed. New York: McGraw-Hill; 2003:265-275.
7. Kin, T.; Rajotte, R. V.; Dufour, J. M.; Korbutt, G. S. Development of an immunoprivileged site to prolong islet allograft survival. Cell Transplant. 11:547-552; 2002.
8. Korbutt, G. S.; Elliott, J. F.; Rajotte, R. V. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46:317-322; 1997.
9. Korbutt, G. S.; Suarez-Pinzon, W. L.; Power, R. F.; Rajotte, R. V.; Rabinovitch, A. Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice. Diabetologia 43:474-480; 2000.
10. Nathan, D. M. Long-term complication of diabetes mellitus. N. Engl. J. Med. 328:1676-1685; 1993.
11. Russell, L. Movement of spermatocytes from the basal to the adluminal compartment of the rat testis. Am. J. Anat. 148:313-328; 1977.
12. Selawry, H. P. Islet transplantation to immunoprivileged Sites. In: Lanza, R. P.; Chick, W. L., eds. Pancreatic islet transplantation, Vol. II Immunomodulation of pancreatic islets. Boca Raton, FL: CRC Press; 1994:75-86.
13. Selawry, H. P.; Cameron, D. F. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant. 2:123-129; 1993.
14. Selawry, H. P.; Whittington, K. Extended allograft survival of islets grafted into intra-abdominally placed testis. Diabetes 33:405-406; 1984.
15. Shamekh, R.; El-Badri, N. S.; Saporta, S.; Pascual, C.; Sanberg, P. R.; Cameron, D. F. Sertoli cells induce systemic donor-specific tolerance in xenogeneic transplantation model. Cell Transplant. 15:45-53; 2006.
16. Shapiro, A. M. J.; Lakey, J. R. T.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
17. Sipione, S.; Simmen, K. C.; Lord, S. J.; Motyka, B.; Ewen, C.; Shostak, I.; Rayat, G. R.; Dufour, J. M.; Korbutt, G. S.; Rajotte, R. V.; Bleackley, R. C. Identification of a novel human granzyme B inhibitor secreted by cultured Sertoli cells. J. Immunol. 177:5051-5058; 2006.
18. Streilein, J. W. Unraveling immune privilege. Science 270:1158-1159; 1995.
19. Suarez-Pinzon, W.; Korbutt, G. S.; Power, R.; Hooton, J.; Rajotte, R. V.; Rabinovitch, A. Testicular Sertoli cells protect islet β-cells from autoimmune destruction in NOD mice by a transforming growth factor-β1- dependent mechanism. Diabetes 49:1810-1818; 2000.
20. Takeda, Y.; Gotoh, M.; Dono, K.; Nishihara, M.; Grochowiecki, T.; Kimura, F.; Yoshida, T.; Ohta, Y.; Ota, H.; Ohzato, H.; Umeshita, K.; Takeda, T.; Matsuura, N.; Sakon, M.; Kayagaki, N.; Yagita, H.; Okumura, K.; Miyasaka, M.; Monden, M. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts. Diabetologia 41:315-321; 1998.
21. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104:1715-1722; 1999.
22. Whitmore, III, W. F.; Karsh, L.; Gittes, R. F. The role of germinal epithelium and spermatogenesis in the privileged survival of intratesticular grafts. J. Urol. 134:782-786; 1985.
23. Yule, T. D.; Montoya, G. D.; Russell, L. D.; Williams, T. M.; Tung, K. S. K. Autoantigenic germ cells exist outside the blood testis barrier. J. Immunol. 141:1161-1167; 1988.